BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue D, Desjardins M, Kaufman GN, Béland M, Al-Tamemi S, Ahmed E, Tao S, Friedel RH, Mourad W, Mazer BD. Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses. Front Immunol 2016;7:558. [PMID: 28003812 DOI: 10.3389/fimmu.2016.00558] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Du H, Xu Y, Zhu L. Role of Semaphorins in Ischemic Stroke. Front Mol Neurosci 2022;15:848506. [DOI: 10.3389/fnmol.2022.848506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 McGettigan SE, Debes GF. Immunoregulation by antibody secreting cells in inflammation, infection, and cancer. Immunol Rev 2021;303:103-18. [PMID: 34145601 DOI: 10.1111/imr.12991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Fard D, Tamagnone L. Semaphorins in health and disease. Cytokine Growth Factor Rev 2021;57:55-63. [PMID: 32900601 DOI: 10.1016/j.cytogfr.2020.05.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
4 Kalmarzi RN, Rajabinejad M, Lotfi R. Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma and allergic diseases. Eur J Pharmacol 2020;881:173209. [PMID: 32454117 DOI: 10.1016/j.ejphar.2020.173209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
5 Rajabinejad M, Asadi G, Ranjbar S, Afshar Hezarkhani L, Salari F, Gorgin Karaji A, Rezaiemanesh A. Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer. Gene 2020;746:144637. [PMID: 32244055 DOI: 10.1016/j.gene.2020.144637] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Smeester BA, Slipek NJ, Pomeroy EJ, Bomberger HE, Shamsan GA, Peterson JJ, Crosby MR, Draper GM, Becklin KL, Rahrmann EP, McCarthy JB, Odde DJ, Wood DK, Largaespada DA, Moriarity BS. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. Oncogene 2020;39:1049-62. [PMID: 31582836 DOI: 10.1038/s41388-019-1041-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Sibai M, Altuntaş E, Süzek BE, Şahin B, Parlayan C, Öztürk G, Baykal AT, Demircan T. Comparison of Gene Expression During Early Phases of Limb Regeneration Between Regeneration-permissive Neotenic and Regeneration-deficient Metamorphic Axolotl.. [DOI: 10.1101/693911] [Reference Citation Analysis]